Oviedo, Spain

Susana Fernandez

This inventor holds 1 USPTO granted patent. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susana Fernandez. Retrieved from https://idiyas.com/inventor/susana-fernandez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Susana Fernandez**

Introduction

Susana Fernandez is a notable inventor based in Oviedo, Spain. With a strong focus on biochemistry and molecular biology, she has made significant contributions through her innovative research and development of new methodologies for oligonucleotide synthesis.

Latest Patents

She holds a patent for "Building blocks for the solution phase synthesis of oligonucleotides." This invention revolves around the preparation of 3'-O and 5'-O-levulinyl nucleosides from common precursors, utilizing an enzymatic approach. This development presents a breakthrough in the efficiency and effectiveness of oligonucleotide production.

Career Highlights

Currently, Susana is associated with Isis Pharmaceuticals, Inc., where she has been actively involved in advancing scientific research and applications in the field of pharmaceuticals. Her expertise in enzymatic processes has been vital in her contributions to the industry.

Collaborations

Throughout her career, Susana has collaborated with distinguished peers such as Yogesh S Sanghvi and Vicente Gotor. These collaborations exemplify her commitment to sharing knowledge and fostering innovation within her field.

Conclusion

Susana Fernandez is an inspiring figure in the realm of inventors, showcasing how creativity and scientific rigor can lead to groundbreaking advancements. Her work continues to influence the synthesis of oligonucleotides, paving the way for new developments in medical and scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…